AI Blogs and Articles
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

AI Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
AIBlogs🧑‍🚀 AGI Partnerships, NVIDIA Announcements & OpenAI’s $135B Shift
🧑‍🚀 AGI Partnerships, NVIDIA Announcements & OpenAI’s $135B Shift
AI

🧑‍🚀 AGI Partnerships, NVIDIA Announcements & OpenAI’s $135B Shift

•October 29, 2025
Matthew Berman
Matthew Berman•Oct 29, 2025
0

Summary

OpenAI completed a legal recapitalization into a public-benefit for-profit structure that gives Microsoft a roughly 27% stake valued at about $135 billion while a controlling non‑profit foundation holds 26%, a move that unlocked $30 billion from SoftBank and includes a $250 billion Azure spend commitment and third‑party AGI verification. The reshaped deal relaxes some exclusivity, lets OpenAI co‑develop with third parties and allows Microsoft to pursue AGI independently, marking a new phase in commercial AI partnerships. Meanwhile, industry shifts accelerated: Amazon said it will cut roughly 14,000 corporate jobs as it pivots around AI, and NVIDIA used GTC to announce major investments and products — including a $1 billion, 2.9% stake in Nokia for 6G hardware, a 100k‑GPU Solstice system, an IGX Thor edge processor and a robotaxi partnership with Uber targeting up to 100,000 Level‑4 vehicles. Together these moves signal consolidation of cloud, compute and telecom bets that will concentrate AI power with a handful of large tech and infrastructure players and reshape talent and competitive dynamics across the sector.

🧑‍🚀 AGI Partnerships, NVIDIA Announcements & OpenAI’s $135B Shift

Read Original Article

Comments

Want to join the conversation?